Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non‐Responders in IPF?

Documenti analoghi

• Optimal clinical practice in IPF and PPF: Integrating the scientific ethos and clinical reasoning
  di: Athol U. Wells
  Pubblicazione: (2024)
• Predicting Failure at Initiation of High‐Flow Nasal Oxygen in Patients With COVID ‐19: Literature Review, Development and Internal Validation of a Prediction Model
  di: Daphne J. T. Sjauw, et al.
  Pubblicazione: (2026)
• Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients
  di: Roger M. Li, et al.
  Pubblicazione: (2025)
• Toward the Development of a Novel Cell Therapy for Pulmonary Arterial Hypertension Using Peripheral Blood Cells
  di: Hidekazu Ishida
  Pubblicazione: (2026)
• High Respiratory Arousal Threshold as a Potential Pathophysiological Biomarker of Excessive Daytime Sleepiness in Obstructive Sleep Apnoea
  di: Danny J. Eckert
  Pubblicazione: (2026)